Research

Found 6 results

Sort by: Author Title [ Year (Asc)]
Filters: Author is RL Findling  [Clear All Filters]
1997
Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M.  1997.  High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo-Controlled Study. Journal of Autism and Developmental Disorders. 27:467-478.
2006
Pandina GJ, Aman MG, Findling RL.  2006.  Risperidone in the Management of Disruptive Behavior Disorders. Journal of Child and Adolescent Psychopharmacology. 16(4):379-392.
Pandina GJ, Aman AG, Findling RL.  2006.  Risperidone in the Management of Disruptive Behavior Disorders. Journal of Child and Adolescent Psychopharmacology. 16(4):379-392.
2007
Miller NL, Findling RL.  2007.  Is Methylphenidate a Safe and Effective Treatment for ADHD-like Symptoms in Children with Pervasive Developmental Disorders? Expert Opinion in Pharmacotherapy. 8(7):1025-1028.
Flanders SC, Findling RL, Youngstrom EA, Pandina GJ, Rupnow MFT, Jensik SE, Carlson GA.  2007.  Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999-2003. Journal of Child and Adolescent Psychopharmacology. 17(3):312-327.
2008
Leskovec TJ, Rowles BM, Findling RL.  2008.  Pharmacological Treatment Options for Autism Spectrum Disorders in Children and Adolescents. Harvard Review of Psychiatry. 16(2):97-112.
|